Amyloid Beta

Amyloid beta (Aβ) is a peptide implicated in Alzheimer's disease and other forms of dementia. It forms when amyloid precursor protein (APP) is improperly cleaved by enzymes. Accumulating Aβ peptides aggregate into plaques, a hallmark of Alzheimer's pathology. These plaques disrupt cell function, trigger inflammation, and promote neuronal death, contributing to cognitive decline and memory loss. Research aims to understand the mechanisms of Aβ formation and aggregation, seeking therapeutic strategies to prevent or reduce plaque buildup. Despite its central role in Alzheimer’s, the exact relationship between amyloid beta and disease progression remains complex, involving genetic, environmental, and biochemical factors.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Facebook
Watsapp